{
    "Trade/Device Name(s)": [
        "AP-1000 Blood Glucose Monitoring System",
        "AP-1000multi Blood Glucose Monitoring System",
        "Blood Glucose Test Strips"
    ],
    "Submitter Information": "Bestgen Biotech Corporation",
    "510(k) Number": "K100437",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090389"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "December 23, 2011",
    "Summary Letter Received Date": "January 6, 2012",
    "Submission Date": "February 1, 2010",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Blood Glucose Test System",
        "Quality Control Material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Palm",
        "Forearm",
        "Thigh"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AP-1000 Meter",
        "AP-1000multi Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Bestgen Biotech AP-1000 and AP-1000multi Blood Glucose Monitoring System and test strips for quantitative glucose measurement.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood from finger, palm, forearm, or thigh by persons with diabetes, using device-specific test strips; not intended for use on neonates.",
    "fda_folder": "Clinical Chemistry"
}